CART 19 T-cell therapy strikes again…
Read the full story of Emma with details and perspectives…
[youtube]http://youtu.be/vHqcpA7KpSc[/youtube]
Read the article of The children’s hospital of Philadelphia…
The race is not fair
Oscar Pistorius, right, called the T44 200m final won by Alan Fonteles Cardoso Oliveira, left, unfair. Pistorius came second. Photograph: Matt Dunham/AP
Yes, Oscar, as much as we all admire you the race is not fair. It has never meant to be. Just as you did change the world of athletics, Alan Oliveira did changed it again until the next race when someone else will change it.
The point of human enhancing is that there is never going to be end to the race, there is never going to be a dominant technology and it is never going to be fair. Because it is actually not race between two humans but between two technologies. And technologies evolve, emerge and prosper in technology life-cycles not in human life-cycles.
BTW see the interactive infografic below for some interesting data about the race:
A new hope
“Vaxil Biotherapeutics Ltd. announced today positive interim results from its Phase I/II therapeutic cancer vaccine trial in Multiple Myeloma patients.
Vaxil is a private clinical stage biopharmaceutical company developing a new class of synthetic T-cell vaccines based on its proprietary VaxHit technology. Vaxil’s lead product ImMucin is an anti-MUC1 therapeutic vaccine and is currently being evaluated in a Phase I/II clinical trial in Multiple Myeloma patients at Hadassah Medical Center, Jerusalem. ImMucin is potentially applicable to over 90% of all types of cancer, encompassing both solid and non-solid tumors. Vaxil is also developing another VaxHit derived vaccine, MTbuVax, for the treatment of Mycobacterium Tuberculosis (MTb) which is in pre-clinical studies. Tuberculosis is one of the biggest causes of mortality worldwide. Recent years have seen a significant rise in the prevalence of treatment resistant TB, particularly in the developed world.”
Face Off/On
After suffering trough a disfigured face for fifeteen years “Richard Lee Norris, of Hillsville, Va., is recovering well after an amazing” medical procedure.
Read the full article which tells the story of a life but also tells the story of a life-long quest.
http://health.yahoo.net/experts/dayinhealth/face-transplant-surgery-richard-lee-norris
3D Printing – the low cost small series production line
MakerBot (http://store.makerbot.com/) have created the first cheap 3d printer which now displays the future of fabrication. DIY robotics have never seemed so attainable. And it would only take another one or twe machine generations before it is used for everything.
What is more amazing is that the creators behind the idea are not stopping there – they have started a community of creative people who would like to exchenge their designs.
They also strated their own internet TV (MakerBot TV) to inform the public the wide possibilities of their product.
A Machine making machine… A community of 3d modelling creative nerds… A tv channel for educating new possibilities… I am convinced. Are you?
The Newest Testament
The newest testament: Robotics student Gildo Andreoni interacts with a Dexmart robotic hand built at the University of Bologna in the Robotville exhibition at the Science Museum on November 29, 2011 in London, England. The Science Museum's Robotville exhibition showcases 20 unique and cutting-edge robots from European research laboratories, it is free to enter and runs from December 1-4, 2011. (Photo by Oli Scarff/Getty Images)
Blogroll
- Aristotle
- Art & Science Factory
- AT-EQUAL
- Charles Stross
- Craig Venter Institute
- Dr. Michio Kaku
- Future Timeline
- Gapminder World
- IEEE Spectrum
- Juan Enriquez
- Kevin Warwick
- Kurzweil Accelerating Intellegence
- Laibach @ NSK
- Mashable: Tech
- Nanoclast (IEEE blog)
- Paul Werbos
- Popular Science's "The future of…"
- Richard Dawkins
- Self-aware systems
- Singularity Hub
- Singularity Institute
- Singularity is near
- Singularity University
- Terry Pratchett
- Vernon Vinge
Welcome , today is Thursday, January 20, 2022